FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973926478> ?p ?o ?g. }

• W1973926478 endingPage "352" @default.
• W1973926478 startingPage "339" @default.
• W1973926478 abstract "Annals of the New York Academy of SciencesVolume 757, Issue 1 p. 339-352 Characterization of Opioid Receptor Types and Subtypes with New Ligands ANNA BORSODI, ANNA BORSODI Institute of Biochemistry Biological Research Center of the Hungarian Academy of Sciences P.O. Box 521 H-6701 Szeged, HungarySearch for more papers by this authorGÉZA TÓTH, GÉZA TÓTH Isotope Laboratory Biological Research Center of the Hungarian Academy of Sciences P.O. Box 521 H-6701 Szeged, HungarySearch for more papers by this author ANNA BORSODI, ANNA BORSODI Institute of Biochemistry Biological Research Center of the Hungarian Academy of Sciences P.O. Box 521 H-6701 Szeged, HungarySearch for more papers by this authorGÉZA TÓTH, GÉZA TÓTH Isotope Laboratory Biological Research Center of the Hungarian Academy of Sciences P.O. Box 521 H-6701 Szeged, HungarySearch for more papers by this author First published: May 1995 https://doi.org/10.1111/j.1749-6632.1995.tb17492.xCitations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Pert , C. B. & S. H. Snyder. 1973. Opiate receptor: Demonstration in nervous tissue. Science 179: 1011–1014. 2 Simon , E. J., J. M. Hiller & I. Edelman. 1973. Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat brain homogenates. Proc. Natl. Acad. Sci. USA 70: 1947–1949. 3 Terenius , L. 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of the guinea-pig ileum. Acta Pharmacol. Toxicol. 32: 317–320. 4 Goldstein , A., L. I. Lowney & B. K. Pal. 1971. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA 68: 1742–1747. 5 Hughes , J., T. W. Smith, H. W. Kosterlitz, L. A. Fothergill, B. A. Morgan & H. R. Morris. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 285: 577–579. 6 Schwyzer , R. 1977. ACTH: A short introductory review. Ann. N.Y. Acad. Sci. 247: 3–26. 7 Kieffer , B. L., K. Befort, C. Gaveriaux-Ruff & C. G. Hirth. 1992. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89: 12048–12052. 8 Evans , C. J., D. E. Keith, Jr., H. Morrison, K. Magendzo & R. H. Edwards. 1993. Cloning of a delta opioid receptor by functional expression. Science 258: 1952–1955. 9 Fukuda , K., S. Kato, K. Mori, M. Nishi & H. Takeshima. 1993. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 327: 311–314. 10 Reisine , T. & G. I. Bell. 1993. Molecular biology of opioid receptors. TINS 16: 506. 11 Raynor , K., H. Kong, Y. Chen, K. Yasuda, L. Yu, G. I. Bell & T. Reisine. 1994. Pharmacological characterization of the cloned kappa, delta and mu opioid receptors. Mol. Pharmacol. 45: 330–334. 12 Uhl , G. R., S. Childers & G. Pasrternak. 1994. An opiate-receptor gene family reunion. TINS 17(3): 89–93. 13 Furst , Zs., B. Buzas, T. Friedmann, H. Schmidhammer & A. Borsodi. 1993. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series. Eur. J. Pharmacol. 236: 209–215. 14 Scmidhammer , H., L. Aeppli, L. Atwell, F. Fritsch, A. E. Jacobson, M. Nebuchla & G. Sperk. 1984. Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonist in the series of (-)-14-methoxy-N-methyl-morphinan-6-ones. J. Med. Chem. 27: 1575–1579. 15 Krizsán, D., E. Varga, S. Hosztafi, S. Benyhe, M. Szucs & A. Borsodi. 1991. Irreversible blockade of the high and low affinity [3H]naloxone binding sites by C-6 derivatives of morphinane-6-ones. Life Sci. 48: 439–451. 16 Schmidhammer , H., W. P. Burkard, L. Eggstein-Aeppli & C. F. C. Smith. 1989. Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-cyclorpopylmethl-4,14-dimethoxymorphinan-6-one, a selective μ-opioid receptor antagonist. J. Med. Chem. 32: 418–421. 17 ÖTvös, F., G. Toth & H. Schmidhammer. 1992. Tritium labeling of cyprodime (= (−)-17-(cyclopropylmethyl)-4,14-dimethoxymorpinane-6-one), a mu receptor-selective opioid antagonist. Helv. Chim. Acta 75: 1718–1720. 18 Jiang , Q., A. E. Takemori, M. Sultana, P. S. Portoghese, W. D. Bowen, H. I. Mosberg & F. Porreca. 1991. Differential antagonism of opioid antinociception by [d-Ala2, Leu5, Cys6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta subtypes. J. Pharmacol. Exp. Ther. 257: 1069–1075. 19 Negri , L., R. L. Potenza, R. Corsi & P. Melchiorri. 1991. Evidence for two subtypes of delta opioid receptor in rat brain. Eur. J. Pharmacol. 196: 335–336. 20 Mosberg , H. I., R. Hurst, V. J. Hruby, K. Gee, H. I. Yamamura, J. J. Galligan & T. F. Burks. 1983. Bis-penicillamine enkephalins possess highly improved specificity towards delta opioid receptors. Proc. Natl. Acad. Sci. USA 80: 5871. 21 Kreil, G. D. Barra, M. Simmaco, V. Erspamer, G. Falconeri-Erspamer, L. Negri, C. Severini, R. Corsi & P. Melchiorri. 1989. Deltophin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. Eur. J. Pharmacol. 162: 123–128. 22 Gacel , G. A., E. Fellion, A. Baamonde, V. Dauge & P. B. Roques. 1990. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systematically active agonist for in vivo studies of delta opioid receptors. Peptides 11: 983. 23 Delay-Goyet, P., M. Ruizgayo, A. Baamonde, G. A. Gacel, J. L. Morgat & P. B. Roques. 1991. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors. In vivo binding and mu receptors versus delta receptors occupancy. Pharmacol Biochem. Behav. 38: 155. 24 Montecucchi , P. C., R. Castiglione, S. Piani, L. Gozini & V. Erspamer. 1981. Aminoacid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phylomedusa sauvageì. Int. J. Pept. Protein Res. 17: 275–283. 25 Melchiori , P., L. Negri, G. Falconeri-Erspamer, C. Severini, R. Corsi, M. Soaje, V. Erspamer & D. Barra. 1991. Structure-activity relationships of the delta-opioid-selective agonists, deltorphins. Eur. J. Pharmacol. 195: 201–207. 26 Salvadori , S., M. Marastoni, G. Balboni, P. A. Borea, M. Morari & R. Tomatis. 1991. Synthesis and structure-activity relationships of deltorphin analogues. J. Med. Chem. 34: 1656–1661. 27 Buzás, B., G. Toth, S. Cavagnero, V. J. Hruby & A. Borsodi. 1992. Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II. Life Sci. 50: PL75–PL78. 28 Sasaiki , Y., A. Ambo & K. Suzuki. 1991. [d-Ala2]Deltorphin analogues with high affinity and selectivity for delta-opioid receptors. Biochem. Biophys. Res. Commun. 180: 822–827. 29 Nevin , S. T., L. Kabasakal, F. Otvos, G. Toth & A. Borsodi. 1993. Characterisation of the novel delta opioid agonist Ile5,6deltorphin II. Neuropeptides 26: 261–265. 30 Portoghese , P. S., M. Sultana, H. Nagase & A. E. Takemori. 1988. Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. J. Med. Chem. 31(2): 281–282. 31 Yamamura , M. S., R. Horvath, G. Toth, F. Otvos, E. Malatynska, R. J. Knapp, F. Porreca, V. J. Hruby & H. I. Yamamura. 1992. Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain. Life Sci. 50: PL119–PL124. 32 Borsodi , A., G. Ozdemirler, S. T. Nevin, L. Kabasakal, F. Otvos & G. Toth. 1993. Binding Characteristics of the delta antagonist [1,5′-3H]naltrindole in rat brain membranes. Br. J. Pharmacol. 109: 17. 33 Dorn , C. R., C. S. Markos, M. S. Dappen & B. S. Pitzele. 1992. Synthesis of [3H]naltrindole. J. Label. Comp. Radiopharm. 31(5): 375–380. 34 Bowen , W. H., S. B. Hellwell, M. Kelemen, R. Huey & D. Stewart. 1987. Affinity labeling of delta opiate receptors using [d-Ala2, Leu5, Cys6]enkephalin. J. Biol Chem. 262: 13434. 35 Mattia , A., S. C. Farmer, A. E. Takemori, M. Sultana, P. S. Portoghese, H. I. Mosberg, W. D. Bowen & F. Porreca. 1992. Spinal opioid delta antinociception in the mouse. Mediation by 5′ NTH-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260: 518–525. 36 Schilller , P. W., T. M.-D. Nguyen, G. Weltrowska, B. C. Wilkes, B. J. Marsden, C. Lemieux & N. N. Chung. 1992. Differential stereochemical requirements of mu versus delta receptors for ligand binding and signal transduction: Development of a new class of potent and highly selective delta-selective peptide antagonists. Proc. Natl. Acad. Sci. USA 89: 11871–11875. 37 Nevin , S. T., G. Toth, T. M.-D. Nguyen, P. W. Schiller & A. Borsodi. 1993. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP. Life Sci. 53: PL57–62. 38 Schiller , P. W., G. Weltrowska, T. M.-D. Nguyen, B. C. Wilkes, N. N. Cheng & C. Lemieux. 1993. TIPP[Y]: A highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. J. Med. Chem. 36: 3182–3187. 39 Wollemann , M., S. Benyhe & J. Simon. 1993. The kappa-opioid receptor: Evidence for the different subtypes. Life Sci. 52: 599–611. 40 Benyhe , S., E. Varga, J. Hepp, A. Magyar, A. Borsodi & M. Wollemann. 1990. Characterization of kappa1 and kappa2 opioid binding sites in frog (Rana esculenta) brain membrane preparation. Neurochem. Res. 15: 899–904. 41 Wolltmann , M., J. Farkas, G. Toth & S. Benyhe. 1994. Characterization of [3H]Metenkephalin-Arg6-Phe7 binding to opioid receptors in frog brain membrane preparations. J. Neurochem. 63: 1460–1465. 42 Erciyas , E. & U. Holzgrabe. 1992. Synthese und stereochemie potentiell stark analgetischer 2,4-m-diarylsubstituierter 3,7-diazabicyclo[3,3,1]nonan-9-on-1,5-diester. Arch. Pharm. (Weinheim) 325: 657–663. 43 Benyhe , S., A. Borsodi, U. Holzgrabe & C. Nachtsheim. 1994. A novel class of kappa opioid receptor agonists with a heterocyclic bicyclo [3,3,1]nonan-9-one skeleton. Regul. Pept. 54(1): 27–28. 44 Varga , E., G. Toth, S. Benyhe., S. Hosztafi & A. Borsodi. 1987. Synthesis and binding of [3H]oxymorphazone to rat brain membrane. Life Sci. 40: 1579–1588. 45 Furst , Zs., T. Friedmann, S. Hosztafi & A. Borsodi. 1994. Different mu opioid receptor subtypes may mediate C-6 substituted oxycodone derivatives induced antinociceptive, gastrointestinal and respiratory actions. Regul. Pept. Suppl. 1: S105–S106. 46 Szucs , M., M. Belcheva, J. Simon, S. Benyhe, G. Toth, J. Hepp, M. Wollemann & K. Medzihradszky. 1987. Covalent labeling of opioid receptors with [3H]-d-Ala2-Leu5-enkephalin chlorometyl ketone: I. Binding characteristics in rat brain membranes. Life Sci. 41: 177–184. 47 Simon , J., M. Szucs, S. Benyhe, G. Toth, J. Hepp, A. Boksoul, M. Wollemann & K. Medzihradszky. 1987. Covalent labelling of opioid receptors with 3H-d-Ala2-Leu5-enkephalin chloromethyl ketone. II. Binding characteristics in frog brain membranes. Life Sci. 41: 185–192. 48 Varga , E., G. Toth, J. Hepp, S. Benyhe, J. Simon, K. Medzihradszky & A. Borsodi. 1988. Synthesis of [3H]-Tyr-d-Ala-Gly-N(Mc)Phe-chloromethyl ketone. Neuropeptides 12: 135–139. 49 Oktem , H. A., J. Moitra, S. Benyhe, C. Toth, A. Lajtha & A. Borsodi. 1991. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]-Tyr-d-Ala-Gly-(Me)Phe-Gly-ol (DAGO) II. Covalent labeling of mu opioid binding site by [3H]-Tyr-d-Ala-Gly-(Me)Phe chloromethyl ketone. Life Sci. 48: 1763–1768. 50 Newman , E. L., A. Borsodi, G. Toth, J. Hepp & E. A. Barnard. 1986. Mu-receptor specificity of the opioid peptide irreversible reagent [3H] DALECK. Neuropeptides 8: 305–315. Citing Literature Volume757, Issue1Diversity of Interacting ReceptorsMay 1995Pages 339-352 ReferencesRelatedInformation" @default.
• W1973926478 created "2016-06-24" @default.
• W1973926478 creator A5011139745 @default.
• W1973926478 creator A5066954927 @default.
• W1973926478 date "1995-05-01" @default.
• W1973926478 modified "2023-10-14" @default.
• W1973926478 title "Characterization of Opioid Receptor Types and Subtypes with New Ligands" @default.
• W1973926478 cites W1521449766 @default.
• W1973926478 cites W1967590730 @default.
• W1973926478 cites W1970319663 @default.
• W1973926478 cites W1970799809 @default.
• W1973926478 cites W1971302523 @default.
• W1973926478 cites W1978182553 @default.
• W1973926478 cites W1979385488 @default.
• W1973926478 cites W1981129697 @default.
• W1973926478 cites W1981402148 @default.
• W1973926478 cites W1984414350 @default.
• W1973926478 cites W1985967865 @default.
• W1973926478 cites W1987339118 @default.
• W1973926478 cites W1988625374 @default.
• W1973926478 cites W1990795738 @default.
• W1973926478 cites W1991125129 @default.
• W1973926478 cites W2009670423 @default.
• W1973926478 cites W2010051841 @default.
• W1973926478 cites W2010233380 @default.
• W1973926478 cites W2012119611 @default.
• W1973926478 cites W2016275972 @default.
• W1973926478 cites W2017016109 @default.
• W1973926478 cites W2021982005 @default.
• W1973926478 cites W2022120454 @default.
• W1973926478 cites W2026376264 @default.
• W1973926478 cites W2039110350 @default.
• W1973926478 cites W2045112376 @default.
• W1973926478 cites W2050929611 @default.
• W1973926478 cites W2052015647 @default.
• W1973926478 cites W2054119130 @default.
• W1973926478 cites W2056607047 @default.
• W1973926478 cites W2075856101 @default.
• W1973926478 cites W2077230174 @default.
• W1973926478 cites W2079172002 @default.
• W1973926478 cites W2085044981 @default.
• W1973926478 cites W2089320192 @default.
• W1973926478 cites W2090031356 @default.
• W1973926478 cites W2102420653 @default.
• W1973926478 cites W2147684527 @default.
• W1973926478 cites W2161080814 @default.
• W1973926478 cites W2320509265 @default.
• W1973926478 cites W2412814035 @default.
• W1973926478 cites W4246024346 @default.
• W1973926478 cites W2047236783 @default.
• W1973926478 doi "https://doi.org/10.1111/j.1749-6632.1995.tb17492.x" @default.
• W1973926478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7611691" @default.
• W1973926478 hasPublicationYear "1995" @default.
• W1973926478 type Work @default.
• W1973926478 sameAs 1973926478 @default.
• W1973926478 citedByCount "18" @default.
• W1973926478 countsByYear W19739264782012 @default.
• W1973926478 countsByYear W19739264782015 @default.
• W1973926478 countsByYear W19739264782019 @default.
• W1973926478 crossrefType "journal-article" @default.
• W1973926478 hasAuthorship W1973926478A5011139745 @default.
• W1973926478 hasAuthorship W1973926478A5066954927 @default.
• W1973926478 hasConcept C170493617 @default.
• W1973926478 hasConcept C185592680 @default.
• W1973926478 hasConcept C2779886867 @default.
• W1973926478 hasConcept C2781063702 @default.
• W1973926478 hasConcept C55493867 @default.
• W1973926478 hasConcept C70721500 @default.
• W1973926478 hasConcept C86803240 @default.
• W1973926478 hasConcept C98274493 @default.
• W1973926478 hasConceptScore W1973926478C170493617 @default.
• W1973926478 hasConceptScore W1973926478C185592680 @default.
• W1973926478 hasConceptScore W1973926478C2779886867 @default.
• W1973926478 hasConceptScore W1973926478C2781063702 @default.
• W1973926478 hasConceptScore W1973926478C55493867 @default.
• W1973926478 hasConceptScore W1973926478C70721500 @default.
• W1973926478 hasConceptScore W1973926478C86803240 @default.
• W1973926478 hasConceptScore W1973926478C98274493 @default.
• W1973926478 hasIssue "1" @default.
• W1973926478 hasLocation W19739264781 @default.
• W1973926478 hasLocation W19739264782 @default.
• W1973926478 hasOpenAccess W1973926478 @default.
• W1973926478 hasPrimaryLocation W19739264781 @default.
• W1973926478 hasRelatedWork W1270150154 @default.
• W1973926478 hasRelatedWork W1487503932 @default.
• W1973926478 hasRelatedWork W164060227 @default.
• W1973926478 hasRelatedWork W1999451252 @default.
• W1973926478 hasRelatedWork W2042876899 @default.
• W1973926478 hasRelatedWork W2081316456 @default.
• W1973926478 hasRelatedWork W2083834776 @default.
• W1973926478 hasRelatedWork W2914391811 @default.
• W1973926478 hasRelatedWork W4211180768 @default.
• W1973926478 hasRelatedWork W961411076 @default.
• W1973926478 hasVolume "757" @default.
• W1973926478 isParatext "false" @default.
• W1973926478 isRetracted "false" @default.
• W1973926478 magId "1973926478" @default.
• W1973926478 workType "article" @default.